2752. Outcomes of Patients with Stenotrophomonas maltophilia infections treated with Cefiderocol in PROVE (Retrospective Cefiderocol Chart Review) Study

BACKGROUND: Gram-negative (GN) bacterial resistance remains an urgent global health problem. Cefiderocol (CFDC) has activity against Stenotrophomonas maltophilia (SM) isolates. PROVE is an ongoing international, retrospective study of CFDC use in GN infections (GNI). This report gives the first desc...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcella, Stephen, Friedman, Bruce, Cai, Bin, Verardi, Stefano, Gozalo, Laurence, Nguyen, Sean T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677458/
http://dx.doi.org/10.1093/ofid/ofad500.2363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677458/
http://dx.doi.org/10.1093/ofid/ofad500.2363

Ejemplares similares